Trials / Completed
CompletedNCT02151838
The Thai Red Cross Society Prevention of Mother-To-Child Transmission of HIV (TRCS PMTCT) Program
The Thai Red Cross AIDS Research Centre
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Thai Red Cross AIDS Research Centre · Academic / Other
- Sex
- Female
- Age
- 15 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To assess the safety and the efficacy of Highly Active Anti-Retroviral Treatment (HAART) for the Prevention of Mother-To-Child Transmission of HIV (PMTCT)
Detailed description
1. To describe characteristics of HIV-infected pregnant women who request HAART from the Thai Red Cross Society PMTCT (TRCS PMTCT) program 2. To study adverse pregnancy outcomes among HIV-infected pregnant women who receive HAART 3. To study adverse events in infants born to women who receive HAART during pregnancy 4. To evaluate risk factors for HAART-related toxicities and for perinatal HIV transmission 5. To establish the pilot model of care for HIV-infected pregnant women in middle income country
Conditions
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2020-12-01
- Completion
- 2021-07-01
- First posted
- 2014-05-30
- Last updated
- 2021-07-12
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02151838. Inclusion in this directory is not an endorsement.